Antibody-based targeted therapies

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Article number	101223
Journal	Best Practice and Research: Clinical Haematology
Volume	33
Issue number	4
DOIs	https://doi.org/10.1016/j.beha.2020.101223
State	Published - Dec 2020

ASJC Scopus subject areas

@article{598270eed3894a9c947e3389d7957c95,

title = "Antibody-based targeted therapies",

author = "Farhad Ravandi",

year = "2020",

month = dec,

doi = "10.1016/j.beha.2020.101223",

language = "English (US)",

volume = "33",

journal = "Best Practice and Research: Clinical Haematology",

issn = "1521-6926",

publisher = "Bailliere Tindall Ltd",

number = "4",

}

TY - JOUR

T1 - Antibody-based targeted therapies

AU - Ravandi, Farhad

PY - 2020/12

Y1 - 2020/12

UR - http://www.scopus.com/inward/record.url?scp=85096107103&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85096107103&partnerID=8YFLogxK

U2 - 10.1016/j.beha.2020.101223

DO - 10.1016/j.beha.2020.101223

M3 - Editorial

C2 - 33279179

AN - SCOPUS:85096107103

SN - 1521-6926

VL - 33

JO - Best Practice and Research: Clinical Haematology

JF - Best Practice and Research: Clinical Haematology

IS - 4

M1 - 101223

ER -